Controlled release dosage for gaba receptor agonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/48 (2006.01) A61K 9/52 (2006.01)

Patent

CA 2560995

The present invention relates generally to pharmaceutical dosage forms having immediate release and controlled release properties that contain a .gamma.- aminobutyric acid (GABAB) receptor agonist, e.g., baclofen, for the treatment of medical conditions, which includes spasms, cramping, and tightness of muscles, associated with ailments such as multiple sclerosis or certain spinal injuries.

La présente invention concerne d'une manière générale des formes galéniques pharmaceutiques à libération immédiate et contrôlée qui renferment un agoniste du récepteur de l'acide .gamma.-aminobutyrique (GABA<SB>B</SB>), tel que le baclofène, et qui servent au traitement d'états pathologiques tels que les spasmes, les crampes et la raideur musculaire associés à des affections telles que la sclérose en plaques ou certains traumatismes spinaux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Controlled release dosage for gaba receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release dosage for gaba receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release dosage for gaba receptor agonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1689456

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.